NasdaqGS:ADUSHealthcare
Addus HomeCare (ADUS) Could Be 12% Below Fair Value As Q2 Results Steady Nerves
Addus HomeCare (ADUS) is back on investors radar after releasing its second quarter 2026 results. The company met revenue expectations, slightly exceeded non GAAP profit forecasts, and kept operating margins stable.
See our latest analysis for Addus HomeCare.
The Q2 report appears to be the main driver of recent trading in Addus HomeCare, with the stock showing a 30 day share price return of 11.05% and a 90 day share price return of 20.85%. Over a longer horizon, total shareholder return sits...